Highlights from Yungang Bio’s 2025 API China Guangzhou Expo
Release time:
2025-05-30 16:26
From May 21 to 23, 2025, the three-day 92nd China International API, Intermediates, Packaging and Equipment Exhibition (API China) successfully concluded at the China Import and Export Fair Complex in Guangzhou.
During the exhibition, Yungang Bio drew numerous business visitors and supply-chain partners to stop by for discussions—ranging from long-standing collaborators to many new clients who came specifically to learn more about the company.
The sales team conducted thorough discussions on the product portfolio, including chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), bilirubin, bile salts, and bile acids. Through face-to-face, in-depth interactions with both new and existing customers, the team gained a more comprehensive understanding of customer needs, the current market landscape, and the industry’s competitive dynamics.
Once again, we would like to extend our heartfelt thanks to all our new and existing customers for gracing us with your presence and support. YunGang Bio will continue to strive to deliver even better products and more dedicated service!
Chenodeoxycholic acid,Ursodeoxycholic acid,Bilirubin,Bile salts,Bile acid
The 94th China International API, Intermediates, Packaging and Equipment Exhibition (API China) will be held at the Shanghai National Exhibition and Convention Center, in conjunction with the 92nd National Pharmaceutical Trade Fair and the 2026 China International Health & Nutrition Expo, all taking place at the same venue and during the same period.
The 2026 China Feed Industry Exhibition will be held from April 18 to 20 at the Nanchang Greenland International Expo Center. Yungang Bio— a national high-tech enterprise specializing in bile acids—cordially invites you to visit Booth B3E193. The company will showcase three key strengths: more than 20 patented inventions in the fields of biopharmaceuticals and animal health, underscoring its patent leadership; a 1,500-square-meter R&D center supported by a team of nearly 60 experts, ensuring robust R&D capabilities; and active participation in the development of national standards coupled with a 10,000-ton-scale smart production line, guaranteeing reliable supply. With a steadfast focus on innovation in bile acids, we look forward to “making waves” together in Nanchang and exploring collaborative opportunities for the future!
From November 12 to 14, 2025, Changde Yungang Bio will make its debut at the API China Chongqing exhibition, showcasing a comprehensive portfolio of bile-related products, including bilirubin, chenodeoxycholic acid, ursodeoxycholic acid, bile salts, and bile acid feed additives. During the event, the company engaged in in-depth exchanges with industry peers on technological trends and market demands, expanded its network of collaborative partners, and received an enthusiastic response from attendees. Looking ahead, Yungang Bio will continue to deepen its expertise in the bile resource sector, delivering higher-quality products and services to customers and working together to create new value for the industry.
Company address: No.8 fenglin road, Sujiadu Community, Zhangmuqiao Street, Changde Economic and Technological Development Zone, Hunan Province